Please Wait...

Blood Pressure (BP) Monitoring

Rapidly evolving research and regulatory markets are focused on BP from both an efficacy and a safety endpoint. Bioclinica is a leader in the implementation and standardization of blood pressure monitoring within the clinical research and development arena. Bioclinica is an international service provider of blood pressure solutions, including Ambulatory Blood Pressure Monitoring, 24 hour pulse wave assessment and automated home and office BP solutions to fit the specific needs of a clinical trial design. Both the home and office BP monitoring include remote data telemonitoring either directly from the patient’s home or clinic to a centralized study data base. Bioclinica can support a series of options to meet the needs of a study from early clinical development through late stage clinical trials and provide a unique blood pressure monitoring solution for you.

Ambulatory Blood Pressure Monitoring (ABPM) - From Efficacy to Safety

Bioclinica began integrating ABPM technology and services within the anti-hypertensive research indication over 25 years ago. Besides being actively used and regarded as a key diagnostic technology within hypertension research, ABPM data are now included in a number of regulatory submissions for novel drugs, serve as a surrogate endpoint to describe the changes in blood pressure over 24 hour time periods (circadian patterns), and are increasingly considered for determining new drug safety during regulatory review.

Bioclinica's full range of ABPM services include:

  • Design and review of protocols for optimal ABPM data collection
  • Case report form (CRF) recommendations
  • Study equipment, validation and hands-on site training
  • Web-based ABPM platform optimized for standardized data collection, security  and study site integration
  • Real-time, onsite, quality control checks
  • Flexibility with ABPM technology to meet the study requirements, therapeutic indication and population
  • Cardiac safety BP threshold notification based on study criteria
  • Advanced statistical reporting on ABPM data

As leaders in the conduct of trials with blood pressure endpoints, Bioclinica maintains a leadership role in shaping regulatory trends through active participation with the Metrics Champions Consortium (MCC) and the Cardiac Safety Research Consortium (CSRC). With unparalleled experience in the management of protocols using ABPM technology, Bioclinica has provided comprehensive ABPM services for pharmaceutical, biotech, and government sponsors. Our ABPM and BP data have been used in NDA submissions as part of the drug approval process. Bioclinica is an international provider of ABPM with more than 36 years of cumulative research experience. We have supported >300 protocols and 300,000 ABPM records across the globe.

Automated Blood Pressure

Automated blood pressure (BP) measurement is increasingly viewed as a preferred alternative to traditional methods of BP measurement in clinical trials. Bioclinica has proven experience integrating automated BP in clinical trials for both office and home environments.

Benefits of Automated office BP monitoring:

  • calibration and standardization of equipment across study sites
  • removal of variability resulting from human/auscultatory bias

Benefits of Automated home BP monitoring:

  • Capture of BP data in a comfortable environment
  • Elimination of the white-coat effect
  • Elimination of transcription errors (when implemented as a remote telemedicine solution)
  • Early identification of trends in BP responses
  • Early endpoint identification (adaptive clinical trial design)

ADDITIONAL RESOURCES

Collection and Analysis of BP data for Clinical Trials

Download WHITE PAPER

Ambulatory Blood Pressure Monitoring

Download DATA SHEET

Cardiovascular Imaging

Download DATA SHEET

Cardiac Safety Solutions

Download BROCHURE

Global Median Beat (GMB)

Download OVERVIEW SHEET

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Our Medical Imaging team is in the spotlight for a job well done! https://t.co/fkmt0zvPhf https://t.co/D7YMTeiSd3
bioclinica (2 days ago)
RT @melfass: "What this agreement means is that we can allocate scarce resources to areas of higher risk" @US_FDA on MRA with @EMA_News at…
bioclinica (3 days ago)
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
bioclinica (5 days ago)
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
bioclinica (5 days ago)
Kristen Mauri shows the @DIA audience the value of risk based monitoring https://t.co/ssJCfc9gQ5
bioclinica (5 days ago)
Innovation Theater Kristin Mauri of @bioclinica presenting on RBM & TQM @DrugInfoAssn #DIA2017 https://t.co/zsGroQcpiU
bioclinica (5 days ago)

Latest Blogs: